Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inter Pharma is a Thailand-based publicly listed healthcare company that develops, manufactures, imports, and distributes health products for humans and companion animals. The group operates across pharmaceuticals, nutraceuticals, cosmeceuticals, pet healthcare, and related hospital/clinic channels, and also provides OEM/ODM manufacturing services through its manufacturing subsidiaries and sites. Its Ayutthaya manufacturing facility produces ophthalmic and conventional pharmaceutical products, including artificial tears and asthma inhalers commercialized in Thailand, while the broader group markets branded wellness and anti-aging products under the Interpharma brand. The company appears primarily commercial rather than a drug-discovery biotech, with revenue driven by marketed products, manufacturing, and distribution rather than a disclosed clinical pipeline. It also owns subsidiaries spanning animal health, pharmaceutical manufacturing, medical equipment, and wellness-related businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inter Pharma.